跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 85,603 条关于
“HER2-expressing cancers”
全部
85,603
临床试验
73,262
药物
1,962
机构
293
资讯
10,086
去年
Cinrebafusp Alfa Shows Promise in HER2-Expressing Solid Tumors: A Phase I Study
5个月前
Phrontline Biopharma's TJ106 Shows Promise Against HER2-Low and ADC-Resistant Tumors in Preclinical Studies
去年
Radiopharm Theranostics' RAD 202 Receives Ethics Approval for Phase 1 Trial in HER2-Expressing Solid Tumors
7年前
AstraZeneca and Daiichi Sankyo Partner in $6.9B Deal for Novel HER2-Targeting Cancer Drug
2年前
FDA Grants Priority Review to Enhertu for HER2-Positive Metastatic Solid Tumors
去年
ExpreS2ion Amends Clinical Trial Protocol to Test Breast Cancer Vaccine in Combination with Antibody-Drug Conjugates
去年
Jazz Pharmaceuticals Acquires Global Rights to Zanidatamab in $1.76 Billion Deal with Zymeworks
去年
Jazz Pharmaceuticals Advances Pipeline with Zanidatamab BLA Acceptance and Strong Financial Performance
去年
ExpreS2ion's ES2B-C001 HER2-Targeting Vaccine Approved for Phase I Trial in Breast Cancer
去年
Enhertu Demonstrates Significant Overall Survival Benefit in HER2-Positive Breast Cancer Phase III Trial
第 1 页,共 1009 页
上一页
下一页